These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8189111)

  • 1. Improved ECG models for estimation of left ventricular hypertrophy progression and regression incidence by redefinition of the criteria for a significant change in left ventricular hypertrophy status. The MRFIT Research Group. Multiple Risk Factor Intervention Trial.
    Zhou SH; Rautaharju PM; Prineas R; Neaton J; Crow R; Calhoun H; Furberg C; Cohen J
    J Electrocardiol; 1993; 26 Suppl():108-13. PubMed ID: 8189111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Dahlof B;
    Circulation; 2003 Aug; 108(6):684-90. PubMed ID: 12885747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians.
    Opadijo OG; Omotoso AB; Akande AA
    Afr J Med Med Sci; 2003 Dec; 32(4):395-9. PubMed ID: 15259925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of electrocardiographic criteria for left ventricular hypertrophy.
    Hsieh BP; Pham MX; Froelicher VF
    Am Heart J; 2005 Jul; 150(1):161-7. PubMed ID: 16084164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients.
    Verdecchia P; Sleight P; Avanzini F; de Simone G; Pede S; Perticone F; Schillaci G; Vanuzzo D; Angeli F; Reboldi GP; Maggioni AP
    Ital Heart J; 2003 Jul; 4(7):479-83. PubMed ID: 14558300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal averaged ECG in different patterns of left ventricular hypertrophy and geometry in hypertension.
    Wojszwiłło A; Łoboz-Grudzień K; Jaroch J
    Kardiol Pol; 2003 May; 58(5):335-43. PubMed ID: 14523481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
    J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM; Devereux RB; Gerdts E; Snapinn SM; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Lindholm LH; Dahlöf B;
    Circulation; 2006 Mar; 113(12):1588-96. PubMed ID: 16534012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and determinants of electrocardiographic left ventricular hypertrophy among a multiethnic population of postmenopausal women (The Women's Health Initiative).
    Oberman A; Prineas RJ; Larson JC; LaCroix A; Lasser NL
    Am J Cardiol; 2006 Feb; 97(4):512-9. PubMed ID: 16461048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The electrocardiogram is an unreliable method of identifying left ventricular hypertrophy in stable, treated angina patients.
    Ang DS; Ti LL; Struthers AD
    J Hum Hypertens; 2008 Jun; 22(6):394-400. PubMed ID: 18354420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A; Adebiyi AA; Aje A; Oladapo OO; Falase AO
    Ethn Dis; 2005; 15(4):578-84. PubMed ID: 16259479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic left ventricular hypertrophy has low diagnostic accuracy in middle-aged subjects.
    Vottonen P; Husso M; Sipola P; Vanninen R; Peuhkurinen K; Magga J
    Blood Press; 2007; 16(5):328-34. PubMed ID: 17852087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement.
    Angeli F; Verdecchia P; Angeli E; Poeta F; Sardone M; Bentivoglio M; Prosciutti L; Cocchieri M; Zollino L; Bellomo G; Rondoni F; Garognoli O; Lenti S; Frigerio C; Gattobigio R; Benemio G; Biscottini B; Panciarola R; Buccolieri M; Liberati R; Trottini M; Cipollini F; Gemelli F; Schillaci G; Porcellati C
    J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):812-6. PubMed ID: 17060807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study.
    Verdecchia P; Reboldi G; Angeli F; Avanzini F; de Simone G; Pede S; Perticone F; Schillaci G; Vanuzzo D; Maggioni AP;
    Am J Hypertens; 2007 Sep; 20(9):997-1004. PubMed ID: 17765142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
    Verdecchia P; Angeli F; Pittavini L; Gattobigio R; Benemio G; Porcellati C
    Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in hypertension control and left ventricular hypertrophy over three years.
    Cuspidi C; Michey I; Meani S; Severgnini B; Fusi V; Salerno M; Valerio C; Magrini F; Zanchetti A
    Ital Heart J; 2002 Sep; 3(9):514-9. PubMed ID: 12407847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic diagnosis of left ventricular hypertrophy: depolarization changes.
    Bacharova L; Estes EH
    J Electrocardiol; 2009; 42(3):228-32. PubMed ID: 19398051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic predictors of left ventricular hypertrophy in pediatric hypertension.
    Ramaswamy P; Patel E; Fahey M; Mahgerefteh J; Lytrivi ID; Kupferman JC
    J Pediatr; 2009 Jan; 154(1):106-10. PubMed ID: 18692200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of left ventricular hypertrophy on early and long-term survival after coronary artery bypass grafting.
    Toumpoulis IK; Chamogeorgakis TP; Angouras DC; Swistel DG; Anagnostopoulos CE; Rokkas CK
    Int J Cardiol; 2009 Jun; 135(1):36-42. PubMed ID: 18579225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.